Back
Corcept Therapeutics Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
67
CORT
Corcept Therapeutics
Last Price:
$75.02
Seasonality Move:
7.08%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.22 | Buy |
| 20-day SMA: | 70.33 | Buy |
| 50-day SMA: | 67.35 | Buy |
| 200-day SMA: | 54.3 | Buy |
| 8-day EMA: | 71.59 | Buy |
| 20-day EMA: | 69.81 | Buy |
| 50-day EMA: | 56.43 | Buy |
| 200-day EMA: | 23.2 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.59 | Buy |
| Relative Strength Index (14 RSI): | 55.18 | Buy |
| Chaikin Money Flow: | 991150 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.63 - 72.93) | Buy |
| Bollinger Bands (100): | (53.41 - 73.51) | Buy |
Corcept Therapeutics Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 73.36 while CORT 8-day simple moving average is 71.22, which is a Buy signal.
-
The stock price of CORT is 73.36 while Corcept Therapeutics 20-day SMA is 70.33, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 67.35 while CORT share price is 73.36, making it a Buy technically.
-
CORT stock price is 73.36 and Corcept Therapeutics 200-day simple moving average is 54.30, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $73.36. The Score for CORT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
7.8B
Price in USD:
73.36
Share Volume:
1.2M
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
27.30
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 73.36 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 73.36 while CORT 8-day exponential moving average is 71.59, which is a Buy signal.
-
The stock price of CORT is 73.36 while Corcept Therapeutics 20-day EMA is 69.81, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 56.43 while CORT share price is 73.36, making it a Buy technically.
-
CORT stock price is 73.36 and Corcept Therapeutics 200-day simple moving average is 23.20, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 3.59, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 55.18, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (66.63 - 72.93), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (53.41 - 73.51), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.